BeOne Medicines Edges Lower as Insider Sales Mount Before Q3 Print
ONC heads into its November 5 earnings release with a notable convergence of insider selling, activist stake reduction, and a stock that has slipped nearly 2% on the week to $370.33. Short interest at BeOne is modest…
